United States Human Microbiome Market Report 2017

August 2017 | 101 pages | ID: U373C104708EN
QYResearch

Abstracts

In this report, the United States Human Microbiome market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Microbiome in these regions, from 2012 to 2022 (forecast).

United States Human Microbiome market competition by top manufacturers/players, with Human Microbiome sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• DuPont
• MicroBiome Therapeutics
• Osel
• Metabiomics Corporation
• Enterome Bioscience
• Yakult
• ViThera Pharmaceuticals
• Vedanta BioSciences

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Prebiotics
• Medical Foods
• Drugs
• Probiotics
• Food
• Devices
• Other Probiotic Supplements

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Microbiome for each application, including

• Diagnostics
• Therapeutics

Contents

United States Human Microbiome Market Report 2017

1 HUMAN MICROBIOME OVERVIEW

1.1 Product Overview and Scope of Human Microbiome
1.2 Classification of Human Microbiome by Product Category
  1.2.1 United States Human Microbiome Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Microbiome Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Prebiotics
  1.2.4 Medical Foods
  1.2.5 Drugs
  1.2.6 Probiotics
  1.2.7 Food
  1.2.8 Devices
  1.2.9 Other Probiotic Supplements
1.3 United States Human Microbiome Market by Application/End Users
  1.3.1 United States Human Microbiome Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Diagnostics
  1.3.3 Therapeutics
1.4 United States Human Microbiome Market by Region
  1.4.1 United States Human Microbiome Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Microbiome Status and Prospect (2012-2022)
  1.4.3 Southwest Human Microbiome Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Microbiome Status and Prospect (2012-2022)
  1.4.5 New England Human Microbiome Status and Prospect (2012-2022)
  1.4.6 The South Human Microbiome Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Microbiome Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Microbiome (2012-2022)
  1.5.1 United States Human Microbiome Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Microbiome Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN MICROBIOME MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Microbiome Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Microbiome Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Microbiome Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Microbiome Market Competitive Situation and Trends
  2.4.1 United States Human Microbiome Market Concentration Rate
  2.4.2 United States Human Microbiome Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Microbiome Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN MICROBIOME SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Microbiome Sales and Market Share by Region (2012-2017)
3.2 United States Human Microbiome Revenue and Market Share by Region (2012-2017)
3.3 United States Human Microbiome Price by Region (2012-2017)

4 UNITED STATES HUMAN MICROBIOME SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Microbiome Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Microbiome Revenue and Market Share by Type (2012-2017)
4.3 United States Human Microbiome Price by Type (2012-2017)
4.4 United States Human Microbiome Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN MICROBIOME SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Microbiome Sales and Market Share by Application (2012-2017)
5.2 United States Human Microbiome Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN MICROBIOME PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Microbiome Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 DuPont
  6.2.2 Human Microbiome Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 DuPont Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 MicroBiome Therapeutics
  6.3.2 Human Microbiome Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MicroBiome Therapeutics Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Osel
  6.4.2 Human Microbiome Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Osel Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Metabiomics Corporation
  6.5.2 Human Microbiome Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Metabiomics Corporation Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Enterome Bioscience
  6.6.2 Human Microbiome Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Enterome Bioscience Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Yakult
  6.7.2 Human Microbiome Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Yakult Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 ViThera Pharmaceuticals
  6.8.2 Human Microbiome Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 ViThera Pharmaceuticals Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Vedanta BioSciences
  6.9.2 Human Microbiome Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Vedanta BioSciences Human Microbiome Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 HUMAN MICROBIOME MANUFACTURING COST ANALYSIS

7.1 Human Microbiome Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Microbiome

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Microbiome Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Microbiome Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN MICROBIOME MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Microbiome Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Microbiome Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Microbiome Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Microbiome Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Microbiome
Figure United States Human Microbiome Market Size (K Units) by Type (2012-2022)
Figure United States Human Microbiome Sales Volume Market Share by Type (Product Category) in 2016
Figure Prebiotics Product Picture
Figure Medical Foods Product Picture
Figure Drugs Product Picture
Figure Probiotics Product Picture
Figure Food Product Picture
Figure Devices Product Picture
Figure Other Probiotic Supplements Product Picture
Figure United States Human Microbiome Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Human Microbiome by Application in 2016
Figure Diagnostics Examples
Figure Therapeutics Examples
Figure United States Human Microbiome Market Size (Million USD) by Region (2012-2022)
Figure The West Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Microbiome Sales (K Units) and Growth Rate (2012-2022)
Figure United States Human Microbiome Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Microbiome Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Human Microbiome Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Human Microbiome Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Microbiome Sales Share by Players/Suppliers
Figure 2017 United States Human Microbiome Sales Share by Players/Suppliers
Figure United States Human Microbiome Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Microbiome Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Microbiome Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Microbiome Revenue Share by Players/Suppliers
Figure 2017 United States Human Microbiome Revenue Share by Players/Suppliers
Table United States Market Human Microbiome Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Microbiome Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Human Microbiome Market Share of Top 3 Players/Suppliers
Figure United States Human Microbiome Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Microbiome Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Microbiome Product Category
Table United States Human Microbiome Sales (K Units) by Region (2012-2017)
Table United States Human Microbiome Sales Share by Region (2012-2017)
Figure United States Human Microbiome Sales Share by Region (2012-2017)
Figure United States Human Microbiome Sales Market Share by Region in 2016
Table United States Human Microbiome Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Microbiome Revenue Share by Region (2012-2017)
Figure United States Human Microbiome Revenue Market Share by Region (2012-2017)
Figure United States Human Microbiome Revenue Market Share by Region in 2016
Table United States Human Microbiome Price (USD/Unit) by Region (2012-2017)
Table United States Human Microbiome Sales (K Units) by Type (2012-2017)
Table United States Human Microbiome Sales Share by Type (2012-2017)
Figure United States Human Microbiome Sales Share by Type (2012-2017)
Figure United States Human Microbiome Sales Market Share by Type in 2016
Table United States Human Microbiome Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Microbiome Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Microbiome by Type (2012-2017)
Figure Revenue Market Share of Human Microbiome by Type in 2016
Table United States Human Microbiome Price (USD/Unit) by Types (2012-2017)
Figure United States Human Microbiome Sales Growth Rate by Type (2012-2017)
Table United States Human Microbiome Sales (K Units) by Application (2012-2017)
Table United States Human Microbiome Sales Market Share by Application (2012-2017)
Figure United States Human Microbiome Sales Market Share by Application (2012-2017)
Figure United States Human Microbiome Sales Market Share by Application in 2016
Table United States Human Microbiome Sales Growth Rate by Application (2012-2017)
Figure United States Human Microbiome Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Human Microbiome Sales Growth Rate (2012-2017)
Figure Merck Human Microbiome Sales Market Share in United States (2012-2017)
Figure Merck Human Microbiome Revenue Market Share in United States (2012-2017)
Table DuPont Basic Information List
Table DuPont Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DuPont Human Microbiome Sales Growth Rate (2012-2017)
Figure DuPont Human Microbiome Sales Market Share in United States (2012-2017)
Figure DuPont Human Microbiome Revenue Market Share in United States (2012-2017)
Table MicroBiome Therapeutics Basic Information List
Table MicroBiome Therapeutics Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MicroBiome Therapeutics Human Microbiome Sales Growth Rate (2012-2017)
Figure MicroBiome Therapeutics Human Microbiome Sales Market Share in United States (2012-2017)
Figure MicroBiome Therapeutics Human Microbiome Revenue Market Share in United States (2012-2017)
Table Osel Basic Information List
Table Osel Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Osel Human Microbiome Sales Growth Rate (2012-2017)
Figure Osel Human Microbiome Sales Market Share in United States (2012-2017)
Figure Osel Human Microbiome Revenue Market Share in United States (2012-2017)
Table Metabiomics Corporation Basic Information List
Table Metabiomics Corporation Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Metabiomics Corporation Human Microbiome Sales Growth Rate (2012-2017)
Figure Metabiomics Corporation Human Microbiome Sales Market Share in United States (2012-2017)
Figure Metabiomics Corporation Human Microbiome Revenue Market Share in United States (2012-2017)
Table Enterome Bioscience Basic Information List
Table Enterome Bioscience Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Enterome Bioscience Human Microbiome Sales Growth Rate (2012-2017)
Figure Enterome Bioscience Human Microbiome Sales Market Share in United States (2012-2017)
Figure Enterome Bioscience Human Microbiome Revenue Market Share in United States (2012-2017)
Table Yakult Basic Information List
Table Yakult Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Yakult Human Microbiome Sales Growth Rate (2012-2017)
Figure Yakult Human Microbiome Sales Market Share in United States (2012-2017)
Figure Yakult Human Microbiome Revenue Market Share in United States (2012-2017)
Table ViThera Pharmaceuticals Basic Information List
Table ViThera Pharmaceuticals Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ViThera Pharmaceuticals Human Microbiome Sales Growth Rate (2012-2017)
Figure ViThera Pharmaceuticals Human Microbiome Sales Market Share in United States (2012-2017)
Figure ViThera Pharmaceuticals Human Microbiome Revenue Market Share in United States (2012-2017)
Table Vedanta BioSciences Basic Information List
Table Vedanta BioSciences Human Microbiome Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vedanta BioSciences Human Microbiome Sales Growth Rate (2012-2017)
Figure Vedanta BioSciences Human Microbiome Sales Market Share in United States (2012-2017)
Figure Vedanta BioSciences Human Microbiome Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Microbiome
Figure Manufacturing Process Analysis of Human Microbiome
Figure Human Microbiome Industrial Chain Analysis
Table Raw Materials Sources of Human Microbiome Major Players/Suppliers in 2016
Table Major Buyers of Human Microbiome
Table Distributors/Traders List
Figure United States Human Microbiome Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Microbiome Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Human Microbiome Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Microbiome Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Microbiome Sales Volume (K Units) Forecast by Type in 2022
Table United States Human Microbiome Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Microbiome Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Microbiome Sales Volume (K Units) Forecast by Application in 2022
Table United States Human Microbiome Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Human Microbiome Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Microbiome Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Microbiome Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources